1 - 1 |
Recent Progress in Molecular Sciences: Reviews from Karolinska Institutet at its 200-year Anniversary Preface Jornvall H, Orrenius S |
2 - 6 |
Amino acid sequence determinants and molecular chaperones in amyloid fibril formation Nerelius C, Fitzen M, Johansson J |
7 - 10 |
Programmed cell clearance: Molecular regulation of the elimination of apoptotic cell corpses and its role in the resolution of inflammation Fadeel B, Xue D, Kagan V |
11 - 18 |
Probing spinal circuits controlling walking in mammals Kiehn O, Dougherty KJ, Hagglund M, Borgius L, Talpalar A, Restrepo CE |
19 - 23 |
Ribonucleotide reductases: Substrate specificity by allostery Reichard P |
24 - 27 |
Beyond the cell surface: New mechanisms of receptor function Ibanez CF |
28 - 32 |
Biochemistry of calcium oscillations Uhlen P, Fritz N |
33 - 38 |
Structural enzymology of sulphur metabolism in Mycobacterium tuberculosis Schnell R, Schneider G |
39 - 45 |
NO-synthase independent NO generation in mammals Lundberg JO, Weitzberg E |
46 - 49 |
Cerebrotendinous xanthomatosis: An inborn error in bile acid synthesis with defined mutations but still a challenge Bjorkhem I, Hansson M |
50 - 57 |
Induction and regulation of CD8+cytolytic T cells in human tuberculosis and HIV infection Brighenti S, Andersson J |
58 - 62 |
The genetic background of gallstone formation: An update Marschall HU, Katsika D, Rudling M, Einarsson C |
63 - 66 |
The role of estrogen receptor beta (ER beta) in malignant diseases-A new potential target for antiproliferative drugs in prevention and treatment of cancer Warner M, Gustafsson JA |
67 - 73 |
Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes Klein G, Klein E, Kashuba E |
74 - 79 |
Coenzyme Q - Biosynthesis and functions Bentinger M, Tekle M, Dallner G |
80 - 84 |
Analytical strategies for characterization of bile acid and oxysterol metabolomes Griffiths WJ, Sjovall J |
85 - 89 |
The p53 tumor suppressor: A master regulator of diverse cellular processes and therapeutic target in cancer Farnebo M, Bykov VJN, Wiman KG |
90 - 94 |
Pharmacogenetic biomarkers as tools for improved drug therapy; emphasis on the cytochrome P450 system Ingelman-Sundberg M, Sim SC |
95 - 100 |
Mitochondrial regulation of cell death: Processing of apoptosis-inducing factor (AIF) Norberg E, Orrenius S, Zhivotovsky B |
101 - 104 |
Fat cell turnover in humans Arner P, Spalding KL |
105 - 110 |
Regulation of the activity of 5-lipoxygenase, a key enzyme in leukotriene biosynthesis Radmark O, Samuelsson B |
111 - 115 |
Novel aspects on pancreatic beta-cell signal-transduction Leibiger IB, Brismar K, Berggren PO |
116 - 119 |
Battle and balance at mucosal surfaces - The story of Shigella and antimicrobial peptides Gudmundsson GH, Bergman P, Andersson J, Raqib R, Agerberth B |
120 - 124 |
Thioredoxin and thioredoxin reductase: Current research with special reference to human disease Holmgren A, Lu J |
125 - 130 |
Superfamilies SDR and MDR: From early ancestry to present forms. Emergence of three lines, a Zn-metalloenzyme, and distinct variabilities Jornvall H, Hedlund J, Bergman T, Oppermann U, Persson B |
131 - 134 |
Molecular aspects in clinical hemostasis research at Karolinska Institutet Blomback M |
135 - 139 |
Advances in eicosanoid research, novel therapeutic implications Haeggstrom JZ, Rinaldo-Matthis A, Wheelock CE, Wetterholm A |
140 - 142 |
The opioid systems - Panacea and nemesis Terenius L, Johansson B |
143 - 146 |
Genetics of complex disorders Kere J |
147 - 151 |
Horizontal gene transfer: You are what you eat Holmgren L |
152 - 156 |
Towards stem cell replacement therapies for Parkinson's disease Arenas E |
157 - 163 |
Understanding specificity in metabolic pathways-Structural biology of human nucleotide metabolism Welin M, Nordlund P |
164 - 169 |
Molecular make-up of the glomerular filtration barrier Patrakka J, Tryggvason K |
170 - 175 |
Fluorescence and single molecule analysis in cell biology Rigler R |